Medical devices, healthcare technology and the business of care
510(k) clearance · K260285

Triad Hydrophilic Wound Dresssing (1964, 2.5 oz); Triad Hydrophilic Wound Dressing (1967, 6 oz)

Coloplast Corp. · Decision date Oct 26, 2026

MEDTECHLEDGER EXPLANATIONK260285

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-10-26 for K260285, submitted by Coloplast Corp. of Minneapolis, Minnesota, and received on 01/29/2026. The device is listed as Triad Hydrophilic Wound Dresssing (1964, 2.5 oz) and Triad Hydrophilic Wound Dressing (1967, 6 oz), with product code FRO and classification name Dressing, Wound, Drug22. In 510(k) terms, SESE means the submission was cleared as substantially equivalent; it is not a PMA approval.

The review panel is recorded as General & Plastic Surgery, while the specialty field in the structured record is listed as Unknown. The source material does not identify a predicate device, describe the technological characteristics compared, or state the basis for the equivalence finding, and no decision statement text is included. The two listed product sizes are the only device variants named; any further components or changed items are not described in the available record.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Unknown
Decision date
Oct 26, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260285
Regulatory pathway
510(k) premarket notification
Product code
FRO
Decision code
SESE
Decision date
Oct 26, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Dressing, Wound, Drug.

Product code
FRO
FDA device class
U

FDA decision timeline

  1. K260285 received

    Application receipt date recorded by FDA.

  2. K260285 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code FRO

Product / regulatory recordCompanyPathwayDecision dateSource
ACTO GmbH510(k) clearanceSep 22, 2026FDA
Magic Science Supply, LLC510(k) clearanceSep 11, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Coloplast Corp.

Headquarters
Not reported
Brand website
coloplast.com
FDA applicant address
Minneapolis, MN

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records